Phase II study of weekly oxaliplatin plus infusional fluorouracil and folinic acid (FUFOX regimen) as first-line treatment in metastatic gastric cancer

Oxaliplatin plus fluorouracil/folinic acid (5-FU/FA) every 2 weeks has shown promising activity in advanced gastric cancer. This study assessed the efficacy and safety of weekly oxaliplatin plus 5-FU/FA (FUFOX regimen) in the metastatic setting. Patients with previously untreated metastatic gastric...

Descripción completa

Detalles Bibliográficos
Autores principales: Lordick, F, Lorenzen, S, Stollfuss, J, Vehling-Kaiser, U, Kullmann, F, Hentrich, M, Zumschlinge, R, Dietzfelbinger, H, Thoedtmann, J, Hennig, M, Seroneit, T, Bredenkamp, R, Duyster, J, Peschel, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2005
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361546/
https://www.ncbi.nlm.nih.gov/pubmed/16012522
http://dx.doi.org/10.1038/sj.bjc.6602697

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361546/
https://www.ncbi.nlm.nih.gov/pubmed/16012522
http://dx.doi.org/10.1038/sj.bjc.6602697

Ejemplares similares